Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
The Bio Report
Levine Media Group
Let's Get Digital with Carrie Charles
Broadstaff
Grain Markets and Other Stuff
Joe Vaclavik
The Ramsey Show Highlights
Ramsey Network
Podcast de Vendas do Diego Maia
Diego Maia
Banking Transformed with Jim Marous
Evergreen Podcasts
Audio Branding
Jodi Krangle
The College Investor Audio Show
The College Investor
Upzoned
Strong Towns
Mastering Risk
Dr. Jeff Donaldson, CD
Home Service Millionaire with Mike Andes
Mike Andes
Money Guy Show
Brian Preston and Bo Hanson
The Ramsey Show
Ramsey Network
The Audacity to Podcast® - tips and how to start and grow profit in podcasting
Daniel J. Lewis
The Abundant Accountant: Leads, Sales & Business Growth for Accounting, Tax and Bookkeeping Professionals
Michelle Weinstein - The Pitch Queen, Sales Strategist
iWork4Him PowerThought
Jim & Martha Brangenberg
Insider Secrets to a Top 100 Podcast with Courtney Elmer | Podcasting Strategies for Growing a Podcast That Converts
Courtney Elmer | PodLaunchHQ.com
The New Abnormal
Sean Pillot de Chenecey
She Coaches Coaches
Candy Motzek | Life & Business Coach
大來國際投顧
大來國際投資顧問股份有限公司
One Part Lion - One Part Lamb with Stephen Scoggins
Stephen Scoggins
eBay the Right Way
Suzanne A. Wells
Hart to Heart
Michelle Hartzman
The Green Blueprint
Latitude Media
The Neurodivergent Entrepreneur
Patrick Casale
FELIX PREHN DAILY MARKET NEWS By Goat Academy
Felix Prehn
Career Sessions
JR Lowry
Everything Cookbooks
Andrea Nguyen, Molly Stevens, Kate Leahy, Kristin Donnelly
Commodity Culture
Jesse Day
Audacity Works
Rachel Strickland
METUS HVAC Tech Show
Mitsubishi Electric Trane US
The Art Of Hospitality
The Art Of Hospitality Podcast
The Art of Network Engineering
Andy and Friends
Global Prosperity Show
Balazs W Kardos
Cables2Clouds
Cables2Clouds
The Unforget Yourself Show
Mark and Katie
She Can Share
Melissa Lea Hughes
Business
Levine Media Group
Acute ischemic stroke is both ubiquitous and undertreated. Only a small fraction of patients currently receive clot-busting drugs or mechanical thrombectomy because of the small treatment window. That’s because existing ...
Plasma gelsolin is an abundant, endogenous regulator of inflammation that is consumed during severe inflammatory insults. When levels fall too low, patients are at higher risk of organ damage and death, particularly in s...
A chronic shortage of high‑quality targets remains one of the biggest constraints in drug discovery, even as therapeutic tools become more powerful and diverse. Regeneron is tackling that problem with its Regeneron Genet...
Epigenetics, the layer of chemical switches that controls how genes are turned on and off, can act like cancer’s operating system when a single epigenetic enzyme becomes essential for a tumor to survive. K36 Therapeutics...
Most marketed antibodies work as antagonists, simply shutting off a receptor, even though many immune, metabolic, and cancer pathways require more nuanced control. Metaphore Biotechnologies' function‑first platform combi...
Cells continuously sense their environment and in response to stressors, adapt, recover, or die. Soley Therapeutics uses its AI platform to capture thousands of intracellular features and map how cells sense, interpret, ...
Promising drugs can become abandoned or underused because of tolerability issues, poor drug‑like properties, or other fixable limitations, even when there is already compelling human evidence that they work. PureTech Hea...
Most cancer therapies hit one or a few pathways that tumors can escape by mutating, activating alternative survival routes, or pumping drugs out, leading to relapse and poor survival in indications such as liver, ovarian...
Gout may be one of the oldest known forms of arthritis, but it remains widely misunderstood, undertreated, and a source of silent suffering for millions of people who are often blamed for their disease rather than offere...
Small molecule drugs and monoclonal antibodies often fall short at addressing severe inflammatory and immune‑mediated diseases. Mesoblast has spent more than 15 years industrializing mesenchymal stromal cell therapies to...
Most existing therapies for multiple sclerosis do a good job of reducing relapses and inflammatory activity, but they largely fail to stop the slow neurodegeneration that drives long-term disability, especially in progre...
The treatment of inflammatory bowel disease currently relies on immunosuppressive therapies that often lose effectiveness, carry infection risks, and drive high treatment cycling. Abivax is betting that fine-tuning, rath...
Many people with the genetic condition Lynch syndrome live with the near‑certainty that they will one day develop cancer and have few options beyond constant screening and, in some cases, preventive surgery. Nouscom is t...
Alzheimer’s disease drug development has long focused on slowing memory loss, but for many families, the tipping point that makes home care impossible is not cognition—it is psychosis. Hallucinations and delusions in Alz...
RICO, the Racketeer Influenced and Corrupt Organizations Act, was originally designed to prosecute organized crime. Today, it sits at the center of a landmark class action against two of the world’s largest pharmaceutica...
Pancreatic cancer remains one of oncology’s deadliest diagnoses, with standard treatments often offering only transient tumor shrinkage at the cost of grueling side effects and rapid resistance. Immuneering is using tran...
Human leukocyte antigen, or HLA, genes, help the immune system tell the difference between the body’s own tissues and outside threats. In some people, certain versions of HLA genes mistakenly flag normal proteins as dang...
Asia is quickly becoming a powerhouse for biopharma innovation, changing ideas about where breakthrough science and fast, cost-efficient drug development happen. A new McKinsey & Company report shows how countries like C...
Leukemia once threatened Aaron Viny’s life, but now it defines his mission. Diagnosed with acute lymphoblastic leukemia as a college student, he survived chemotherapy, central nervous system relapse, and an allogeneic st...
When Amy Burroughs stepped in as CEO of Terns Pharmaceuticals, she not only had to fill a void created by the death of her predecessor, but also lead a strategic shift from an increasingly crowded area of metabolic disea...
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.